Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00485082 · ClinicalTrials.gov registry record
Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner
A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).
- Completed
- Registry status
- 50
- Enrollment target
NCT00485082 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 50 participants.
The verdict
NCT00485082 has completed, sponsored by National Human Genome Research Institute (NHGRI).
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
This study will examine the experience of disclosing a cystic fibrosis (CF) diagnosis to a dating partner. CF has implications for potential life partners (issues of fertility, decreased life span and an increasing need for medical management with age) that may make disclosure particularly sensitive. An understanding of the disclosure process may provide insight into ways health care practitioners can support their patients during this process. People between 21 and 35 years of age with CF who have been in at least one dating relationship may be eligible for this study. Participants are interviewed by telephone about their experiences living with cystic fibrosis and telling dating partners about their diagnosis. The interview includes questions about: * Past experiences disclosing their CF diagnosis to a dating partner * What information was disclosed versus what was not disclosed * Why certain information was disclosed or not disclosed * Positive and negative implications of the disclosure or non-disclosure The interview lasts about 60 minutes and is tape-recorded for later review and analysis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00485082
The ClinicalTrials.gov registry entry for NCT00485082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00485082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00485082 about?
NCT00485082 is a clinical study titled "Disclosing a Cystic Fibrosis Diagnosis to a Dating Partner". This study will examine the experience of disclosing a cystic fibrosis (CF) diagnosis to a dating partner. CF has implications for potential life partners (issues of fertility, decreased life span and an increasing need for medical management with age) that may make disclosure particularly sensitive...
What is the current status of trial NCT00485082?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2007-06-05.
Who is sponsoring clinical trial NCT00485082?
This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.